Sativa Group Plc [AQSE:SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in July.
We are pleased to announce that our strong group sales momentum continues with another record-breaking month of sales for the month of July. There continues to be very strong demand for our Goodbody sanitiser range which is sold to both consumers and custom branded for corporate clients.
We continue to develop our core CBD offer, with the launch of our newly combined Goodbody website “goodbodystore.com” which features both our Wellness and Botanicals ranges has gone extremely well. This site provides the platform for product line expansion and focused efforts to drive sales growth. The new Goodbody Wellness line featuring CBD with vitamin D is being received very well by both consumers and retailers.
Henry Lees-Buckley, Chief Executive Officer of Sativa Group, said: “We are delighted to see the continued sales momentum. We are working aggressively to build out both the platform online and expand the product range to anticipate and satisfy consumer demand. Our focus on regulatory compliance holds steadfast and we are actively engaged in the FSA Novel Foods accreditation process. Our combination with StillCanna Inc is on track and is expected close in early to mid-September. This creates a true “Seed to consumer CBD company”.
